Resource 05 · Regulatory & Governance
Compliance and Documentation Framework
How can an organisation demonstrate that its products, processes, claims and records satisfy the obligations applicable to each market?
Developed and curated by Shamim Quresh · Editorial methodology
Level 1 · Understand · about two minutes
The framework at a glance
Compliance is an ongoing, market-specific system of obligations and evidence — not a certificate or a folder of PDFs. A document can exist and still be outdated, unsigned, irrelevant to the market or disconnected from the product actually sold.
- Controlling question
- What evidence is required for this product in each destination market?
- Key decision record
- Market-specific requirements register and evidence index
- Role in the library
- Establishes the applicable obligations and maintains supporting evidence
- Applies to
- Cosmetic and personal-care products in Kenya, the European Union, the United States and China, as worked examples. Classification can change with claims. This framework identifies questions; it does not determine legal compliance.
The 7 evidence layers
Evidence layer 01 of 7
Corporate and market identity
Who is legally accountable in each market?
Essential deliverables
- Regulatory requirements register
- Document master index
- Evidence traceability matrix
- Change-control records
- Supplier documentation
- Gap assessment and corrective plan
- Product dossier per market
- Audit reports
Common mistakes
- Treating a certificate as compliance.
- Transferring an EU file wholesale to another market.
- Presenting a study on an older formula as current evidence.
- Reporting 'percent complete' instead of blocking gaps.
- Confusing a document's approval with the product's market approval.
After reading, you should be able to
- Start with classification and market mapping.
- Organise evidence in seven layers with a control question each.
- Run a cross-document coherence test from marketed SKU to dispatched batch.
- Assess the impact of a change before implementing it.
How it connects to the other frameworks
Level 2 · Study · the complete methodology
Work the method
Purpose and essential distinction
Compliance is an ongoing, market-specific system of obligations and evidence—not a certificate, one-time checklist or collection of PDF files. A document can exist and still be inaccurate, outdated, unsupported, unsigned, jurisdictionally irrelevant or disconnected from the marketed product. The question is: Which legal or contractual requirement applies; who is accountable; what demonstrates conformity; and is that evidence current for this exact product, claim and market?
Start with classification and market mapping
For each intended destination, identify: product category and use; legal classification; economic operators and responsible parties; ingredient restrictions; permitted claims; safety assessment; labelling and languages; facility requirements; product notification/listing/registration; record retention; importer/distributor responsibilities; adverse-event reporting; environmental/packaging rules; and post-market vigilance. Review the current official text and competent authority guidance. Classification may change when claims change: a sunscreen, antiseptic or therapeutic treatment can enter a different regulatory framework from ordinary skincare.
Regulatory examples — not a universal checklist
- European Union: Regulation (EC) No 1223/2009 establishes cosmetics obligations including safety assessment, the Cosmetic Product Safety Report, Product Information File, responsible person, labelling and notification provisions. Keep amendments and the actual market date under review.
- United States: MoCRA introduces obligations including safety substantiation and, for covered entities, facility registration and product listing; exceptions and other requirements apply. FDA registration/listing is not product approval. Product classification and specific claims can trigger other rules.
- Kenya: Verify the applicable KEBS standards, conformity/mark requirements, product category and current administrative procedures directly for the product and domestic or export route. Do not assume a certificate for one item or market covers all SKUs or destinations.
- China and other export destinations: Determine the current product category, responsible entity, filing/registration pathway, ingredient, testing and labelling obligations from the competent authority before planning entry. Do not transfer an EU file wholesale and call it locally compliant.
- ISO 22716 and ICH: ISO 22716 offers cosmetics GMP guidance. ICH Q8/Q9/Q10 are pharmaceutical quality frameworks useful for scientific thinking; they do not automatically create cosmetics legal requirements.
Seven layers of the evidence architecture
| Layer | Typical records | Central control question |
|---|---|---|
| 1. Corporate and market identity | Legal entity, manufacturer, importer, responsible person, contracts | Who is legally accountable in each market? |
| 2. Product identity | SKU, product family, formula, pack, label, intended use, claims versions | Which exact product is being discussed? |
| 3. Material and supplier | Supplier qualifications, specifications, COAs, traceability, safety information | Do we know what entered the product and whether it was acceptable? |
| 4. Scientific substantiation | Development data, stability, microbiology, compatibility, safety and claims evidence | What scientific evidence supports the product and its claims? |
| 5. Production and quality | GMP procedures, batches, tests, deviations, release, change control | Was this lot produced and released under control? |
| 6. Market authorisation/notification | Local assessments, filings, labels, responsible-party evidence | Was the correct market-specific route followed? |
| 7. Post-market governance | Complaints, adverse events, recalls, trends, CAPA, renewals | Can new information trigger timely action? |
Requirements register schema
| Field | Purpose |
|---|---|
| Requirement ID / source | Exact law, clause, standard, contract and official link |
| Jurisdiction / category | Where and to which product classification it applies |
| Legal status | Binding law, guidance, voluntary standard or customer requirement |
| Obligation | Plain-language actionable interpretation, reviewed by competent owner |
| Evidence required | Document/test/procedure with specific acceptance condition |
| Product / claim / formula revision | Link to the actual subject of evidence |
| Responsible person / reviewer | Maker, approver and, where applicable, legal responsible entity |
| Effective date / review trigger | Amendment, formula or artwork change, market extension, expiry |
| Status / gap / corrective plan | Compliant, not applicable with reason, pending, blocked or noncompliant |
| Evidence location / version | Controlled file identifier and immutable revision history |
A defensible document-control lifecycle
Request → draft → technical review → quality/regulatory review → approval → effective release → use → periodic review or change trigger → supersession → retention/disposal under approved rules. Every controlled document needs an owner, ID, scope, version, effective date, approval evidence and relationship to affected products. An obsolete SOP should remain available as an archival record but inaccessible for routine production use. Use access rules to protect confidential formulas and personal data without hiding necessary evidence from authorised reviewers.
Cross-document coherence test
The most valuable audit is often not “Does a test report exist?” but “Does the test report refer to the same product as the label and the factory record?” Verify a consistent chain:
Marketed SKU → product description and claims → formula revision → raw-material grades → manufactured test batch → analytical/stability/safety evidence → packaging revision → market label → production batch → release/dispatch.
If any link is missing, note the gap. A historical study on a materially different formula cannot silently be presented as current evidence; assess bridging scientifically and document the conclusion.
Change-impact matrix
| Proposed change | Typical impact questions | Possible affected evidence |
|---|---|---|
| Fragrance or preservative change | Safety, allergen/label, microbiology, stability, supplier | Formula, safety assessment, challenge tests, artwork |
| Packaging material/closure change | Migration/compatibility, dispensing, protection, shelf life | Compatibility, stability, specifications, production setup |
| Manufacturing site or scale change | Equipment, process equivalence, quality agreement, filings | Transfer and qualification records, registrations as applicable |
| Claim wording change | Classification, substantiation, consumer interpretation | Claims matrix, label, regulatory review, marketing approvals |
| New export market | Ingredient legality, language, operator, filings, claims | Jurisdiction-specific dossier and labels |
| Supplier/grade substitution | Impurities, performance, equivalence and traceability | Supplier qualification, specifications, verification studies |
Changes require documented impact assessment before implementation. The matrix prompts investigation; it does not determine whether retesting or notification is legally required in every case.
Audit and gap-resolution method
- Define scope and governing market/product revision.
- Compile the authoritative requirements register and evidence index.
- Sample vertically: trace one finished lot from raw material through sales channel.
- Sample horizontally: compare one high-risk requirement across all affected SKUs.
- Rate gaps by severity, occurrence/exposure and detectability with a documented rationale; avoid treating a single numeric risk score as sufficient for severe hazards.
- Contain immediate safety or legal risks before optimisation.
- Assign corrective actions, accountable owners and evidence-based effectiveness checks.
- Repeat the audit after a relevant change or scheduled review.
Creative and efficient problem-solving methods
- Evidence graph, not folder maze: Link each requirement to every supporting record and affected product revision. One changed formula can reveal impacted dossiers instantly.
- Compliance diff engine: On a proposed change, compare old and new ingredient lists, claims, labels and manufacturing site metadata; flag likely review tasks for a qualified human.
- Red-team dossier review: Have someone unfamiliar with the product attempt to prove the marketed claims and reconstruct one batch from the records. Any ambiguity is a system defect.
- One fact, many views: Maintain one controlled source for ingredient identity, formula revision and legal entities; generate market-specific indexes rather than duplicating uncontrolled versions.
- Regulatory horizon scan: Assign owners to track official amendments, enforcement guidance and upcoming deadlines; log what changed and which SKUs are affected.
- Minimum viable audit trail: Capture critical evidence during the work itself rather than reconstructing signatures or batch facts months later. Never backdate records.
- Exception-first dashboard: Show overdue critical gaps, expired evidence, unapproved changes and unresolved complaints ahead of “percent complete.” A dossier that is 98% complete may still be unmarketable.
Example documentation request pack
When a distributor asks for evidence, first ask: target market, SKU/revision, role in supply chain, specific purpose, confidentiality needs and legal basis. Provide an indexed, access-controlled pack of relevant approved documents; redact proprietary information where lawful and agreed; preserve full source evidence internally. A generic certificate bundle can be both excessive and inadequate.
Readiness status vocabulary
Use Verified, Verified with limitations, Pending evidence, Not applicable (justified), Nonconforming, and Blocked. Reserve “approved for sale” for the legally and organisationally authorised decision with the exact market and version identified. Do not confuse a document's approval status with product market approval.
Working documents
Document master index
| Field | Purpose |
|---|---|
| Document ID and title | Unique, never recycled |
| Type | Policy, SOP, work instruction, specification, form, record, report, external document |
| Evidence layer | Which of the seven layers it belongs to |
| Products, revisions and markets covered | The exact subjects it applies to |
| Owner and approver | Named roles |
| Version and effective date | The current controlled version |
| Review trigger and next review date | Event or date that forces review |
| Location | Controlled storage reference |
| Status | Draft, in review, effective, superseded, obsolete |
Evidence traceability matrix
One row per marketed claim or requirement, with columns that follow the coherence chain: marketed SKU → claim or requirement → formula revision → test batch → evidence ID and version → packaging revision → label version → status. A gap anywhere in the row is a finding.
Change-control form
Change ID; description; reason; products, revisions and markets affected; impact assessment by function (formulation, safety, regulatory, quality, packaging, supply, marketing); tests or reviews required; approvals; implementation date; training; post-change verification; closure.
Supplier documentation checklist
For each material and grade: specification; certificate of analysis for each lot; safety data sheet; composition or INCI information sufficient for the safety assessment; impurity and allergen statements where relevant; regulatory statements for each target market; change-notification agreement; origin and traceability information. Supplier statements are inputs to your assessment, not substitutes for it.
Regulatory gap assessment
For each requirement in the register: requirement and source → current evidence → gap → severity and exposure → containment if needed → corrective action, owner and date → effectiveness check.
Product dossier checklist
Organise by evidence layer: who is responsible; exactly which product; which materials; what science supports it; how it was made and released; which market route was followed; how new information is monitored. In the EU this is structured as the Product Information File required by Regulation (EC) No 1223/2009; other markets have their own structures.
Document approval and revision workflow
Request → draft → technical review → quality or regulatory review → approval → effective release → use → periodic review or change trigger → supersession → retention. Every step leaves a record; nothing is backdated.
Failure scenarios and troubleshooting
| Symptom | Likely cause | Response |
|---|---|---|
| Test report refers to a different formula from the label | Formula changed without a change-impact assessment | Assess bridging scientifically or retest; document the conclusion |
| Distributor receives a certificate for the wrong market | Generic document bundle instead of a market-specific index | Respond from the register: market, SKU, revision, purpose |
| Two versions of an SOP in use | Superseded copies not withdrawn from the floor | Controlled distribution; withdraw and reconcile copies |
| "98% complete" dossier still cannot be sold | Percent-complete hides a blocking gap | Exception-first dashboard: blocked and nonconforming items first |
| Records completed after the event | Evidence captured as an afterthought | Capture at the point of work; never backdate |
Level 3 · Apply · educational tools
Practise the method
These tools are teaching simulations. They use illustrative data, show their assumptions and are not validated scientific, regulatory or financial instruments.
Documentation architecture
The seven evidence layers and typical controlled documents in each: purpose, contents, owner, reviewer, approval, related documents, version control and revision triggers.
Layer 1 · Corporate and market identity
Legal entity and operator register
- Purpose
- Records each legal entity and its role: brand owner, manufacturer, importer, distributor, responsible person.
- Typical contents
- Registered names and addresses, registration numbers, roles by market, contacts.
- Author or owner
- Company secretary or regulatory lead
- Reviewer
- Legal adviser
- Approval
- Director
- Related documents
- Contracts; labels; market filings
- Version control
- Version and effective date; history retained
- Events that trigger revision
- New market; change of importer, distributor or responsible person; change of address
A typical documentation structure for teaching. Ownership and approval routes vary by organisation size, market and contract.
Limits of this tool. A typical structure. Ownership, approval routes and required records vary by organisation, market and contract.
Regulatory market comparison
Kenya, the European Union, the United States and China compared for two defined products: an ordinary facial moisturiser and a tinted sunscreen. Each entry is labelled as statutory, guidance, voluntary or still to be verified, with its source.
Product assumption. No SPF, no therapeutic or medicinal claims, sold to consumers. Treated as an ordinary cosmetic. Last reviewed: 18 November 2026.
| Requirement area | Kenya | European Union | United States | China |
|---|---|---|---|---|
| Governing framework | StatutoryVerify locallyStandards Act and Kenya Standards, administered by the Kenya Bureau of Standards (KEBS). Products with medicinal claims may fall under the Pharmacy and Poisons Board.Verify with: Pharmacy and Poisons Board (whether any claim makes the product medicinal) and KEBSSource: Kenya Bureau of Standards (opens in a new tab) | StatutoryRegulation (EC) No 1223/2009 on cosmetic products.Source: European Union, EUR-Lex (opens in a new tab) | StatutoryFederal Food, Drug, and Cosmetic Act as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).Source: U.S. Food and Drug Administration (opens in a new tab) | StatutoryCosmetics Supervision and Administration Regulation (in force 1 January 2021), supervised by the National Medical Products Administration (NMPA).Source: National Medical Products Administration, China (opens in a new tab) |
| Classification | Verify locallyIdentify the applicable Kenya Standards: KS 2937:2021 (safety of cosmetic products — general requirements) and any product-specific standard.Verify with: KEBS (Standards Development and Certification); obtain KS 2937:2021 itself from the KEBS web storeSource: Kenya Bureau of Standards web store (opens in a new tab) | StatutoryCosmetic product, judged case by case on its function and presentation.Source: European Union, EUR-Lex (opens in a new tab) | StatutoryCosmetic, unless its intended use or claims make it a drug.Source: U.S. Food and Drug Administration (opens in a new tab) | StatutoryGeneral cosmetic.Source: National Medical Products Administration, China (opens in a new tab) |
| Pre-market route | StatutoryMade in Kenya: the KEBS Standardization Mark is mandatory for locally manufactured products. Imported: Pre-Export Verification of Conformity (PVoC) in the country of supply, unless exempt.Source: Kenya Bureau of Standards (opens in a new tab) | StatutoryNo pre-market approval. The product is notified once through the Cosmetic Products Notification Portal before it is placed on the market.Source: European Union, EUR-Lex (opens in a new tab) | StatutoryNo FDA pre-market approval for cosmetics (colour additives excepted). Facility registration and product listing are required unless an exemption applies; they are not approval.Source: U.S. Food and Drug Administration (opens in a new tab) | StatutoryFiling with NMPA: before import for imported products, before placing on the market for domestic products.Source: National Medical Products Administration, China (opens in a new tab) |
| Responsible party | StatutoryThe local manufacturer holds the mark permit; for imports, the importer must ensure goods meet the applicable standards.Source: Kenya Bureau of Standards (opens in a new tab) | StatutoryA responsible person established in the EU must be designated for each product.Source: European Union, EUR-Lex (opens in a new tab) | StatutoryThe 'responsible person' — the manufacturer, packer or distributor named on the label.Source: U.S. Food and Drug Administration (opens in a new tab) | StatutoryVerify locallyThe filer; overseas companies act through a domestic responsible person in China. Confirm the current requirements.Verify with: NMPA, through a qualified domestic responsible person or regulatory agent in ChinaSource: National Medical Products Administration, China (opens in a new tab) |
| Safety evidence | Verify locallyProduct testing against the applicable standard and factory inspection form part of certification. Confirm the tests required for your product category.Verify with: KEBS Quality Assurance and Inspection, and a testing laboratory KEBS recognises for the product categorySource: Kenya Bureau of Standards (opens in a new tab) | StatutoryRegulatory guidanceSafety assessment and a cosmetic product safety report before placing on the market, held in the Product Information File. Commission guidelines explain Annex I.Source: European Commission, EUR-Lex (opens in a new tab) | StatutoryThe responsible person must ensure, and keep records showing, adequate safety substantiation.Source: U.S. Food and Drug Administration (opens in a new tab) | Verify locallyThe filing dossier includes product safety information and support for efficacy claims. Confirm current dossier requirements with NMPA.Verify with: NMPA filing requirements, with a China cosmetics regulatory specialistSource: National Medical Products Administration, China (opens in a new tab) |
| Manufacturing practice | Voluntary standardVerify locallyISO 22716 is published as a Kenya Standard (KS ISO 22716). Check whether your certification scheme requires it.Verify with: KEBS certification officer for your product schemeSource: Kenya Bureau of Standards web store (opens in a new tab) | StatutoryVoluntary standardThe regulation requires good manufacturing practice. ISO 22716 is the standard widely used to demonstrate it.Source: International Organization for Standardization (opens in a new tab) | StatutoryVoluntary standardVerify locallyMoCRA requires FDA to establish cosmetic GMP regulations. Check whether a final rule is in force on your market date. ISO 22716 is voluntary.Verify with: FDA Office of Cosmetics and Colors guidance, or a US regulatory specialistSource: U.S. Food and Drug Administration (opens in a new tab) | Verify locallyChina sets its own production quality requirements. Do not assume an EU or ISO 22716 file transfers wholesale.Verify with: NMPA, with a China cosmetics regulatory specialistNo primary source checked |
| Labelling | Verify locallyConfirm the labelling standard and language requirements with KEBS for your product category.Verify with: KEBS, for the labelling standard and language requirements that apply to cosmeticsNo primary source checked | StatutoryLabel content is set by the regulation, in the languages each member state requires.Source: European Union, EUR-Lex (opens in a new tab) | StatutoryVerify locallyFederal labelling rules apply; confirm current MoCRA labelling provisions for your product.Verify with: FDA labelling guidance, or a US regulatory specialistSource: U.S. Food and Drug Administration (opens in a new tab) | Verify locallyChinese-language labelling is required. Confirm current label rules.Verify with: NMPA and SAMR labelling rules, with a China cosmetics regulatory specialistNo primary source checked |
| Post-market | StatutoryKEBS market surveillance can issue warnings, recall products, impose fines and revoke permits.Source: Kenya Bureau of Standards (opens in a new tab) | StatutorySerious undesirable effects must be reported to the competent authority; the Product Information File must be kept available.Source: European Union, EUR-Lex (opens in a new tab) | StatutorySerious adverse events must be reported to FDA within 15 business days. FDA has mandatory recall authority.Source: U.S. Food and Drug Administration (opens in a new tab) | Verify locallyAdverse reaction monitoring applies. Confirm obligations for the filer and domestic responsible person.Verify with: NMPA, with the domestic responsible personNo primary source checked |
- Statutory
- A legal obligation in that market.
- Regulatory guidance
- Official guidance on how to meet the law; not itself the law.
- Voluntary standard
- A published standard; binding only where law, certification or contract makes it so.
- Internal practice
- Good professional practice the framework recommends.
- Verify locally
- Not confirmed against a primary source for this library. The named authority or a qualified regulatory specialist must confirm it before any decision is made.
Illustrative comparison for two defined product assumptions. It is not legal advice, it is not complete, and requirements change. Check the official sources and current law for your exact product, claims, role and market date.
Limits of this tool. Illustrative and incomplete. It is not legal advice, and it does not show that any product complies. Laws change: check the official sources for your exact product, claims and market date.
Change impact assessment
Choose one or more proposed changes to see the documents, tests, reviews and approvals they may affect.
1 change selected. Items affected by more than one change are listed once, with every change that touches them.
Documents that may need revision (5)
- Packaging specification
- Artwork
- Stability and compatibility reports
- Filling instructions
- Product master record
Tests that may be needed (3)
- Compatibility and stability in the new pack
- Dispensing and closure integrity
- Line trials
Reviews to perform (3)
- Label space and mandatory text
- Environmental or packaging rules per market
- Shelf-life statement
Approvals to obtain (4)
- Technical lead
- Operations
- Quality
- Regulatory per market
Possible impact areas only. This tool identifies possible impact areas for a qualified person to assess. It does not determine whether retesting, notification or approval is legally required in any market. Record the assessment in a change-control form before implementing the change.
Limits of this tool. It identifies possible impact areas for a qualified person to assess. It does not determine legal compliance or whether retesting or notification is legally required.
Working templates
Download the templates
Each file includes instructions, field definitions and example entries. Example entries are marked ILLUSTRATIVE and describe fictional products. All ten templates are listed on the library page.
- Download Regulatory Requirements Register Excel workbook (.xlsx)
Regulatory Requirements Register
The ten-field register schema from the framework, with legal-status and readiness vocabularies built in.
- Download Product Documentation Master Index Excel workbook (.xlsx)
Product Documentation Master Index
Every controlled document by evidence layer, with owner, version, review trigger and status, plus an evidence traceability sheet.
References and further reading
Sources
Primary sources for verification. Listing a source is not a claim that every requirement in it applies to every product. Recheck laws, standards and market dates before commercial use.
Statutory regulation
Regulation (EC) No 1223/2009 on cosmetic products (recast) (opens in a new tab)
Requires a responsible person in the EU, a safety assessment and cosmetic product safety report before placing on the market, a Product Information File, labelling and notification.
Regulatory guidance
Guidance to responsible persons; it does not replace the qualified safety assessor, who alone carries out the safety assessment.
Official regulator information
Cosmetics & U.S. Law (Modernization of Cosmetics Regulation Act of 2022) (opens in a new tab)
MoCRA added requirements for adverse event reporting, facility registration and product listing, and safety substantiation, and gave FDA records access and mandatory recall authority. FDA must also establish GMP regulations for cosmetic facilities.
Official regulator information
Registration & Listing of Cosmetic Product Facilities and Products (opens in a new tab)
Facility registration is renewed every two years. Registration and listing are not FDA approval.
Official regulator information
Questions and Answers: FDA's regulatory actions on over-the-counter sunscreen (opens in a new tab)
Sunscreens are regulated as over-the-counter drugs under monograph M020. In 2026 FDA added bemotrizinol as a permitted active ingredient and removed PABA and trolamine salicylate.
National standard
Listed by KEBS alongside KS ISO 22716 and microbiology standards for cosmetics. The standard itself is sold by KEBS and was not reviewed for this library.
Official regulator information
Certification Body FAQs (Standardization Mark and Import Standardization Mark) (opens in a new tab)
The Standardization Mark is mandatory for locally manufactured products; the Diamond Mark is voluntary.
Official regulator information
Pre-Export Verification of Conformity (PVoC) services (opens in a new tab)
Imported goods are certified against applicable Kenya standards in the country of origin before shipment; otherwise they face destination inspection and testing.
Official regulator information
Market Surveillance FAQ (opens in a new tab)
KEBS can issue warnings, recall products, impose fines, revoke permits or prosecute, depending on the level of non-compliance.
Statutory regulation
Provisions for Registration and Filing of Cosmetics (SAMR Order No. 35) (opens in a new tab)
Special cosmetics (including sunscreens) require registration; general cosmetics require filing.
Voluntary standard
Last reviewed and confirmed by ISO in 2022, so this edition remains current.
Pharmaceutical methodology
Q8, Q9 and Q10 are designed to work together to support science- and risk-based approaches to quality.
Links and summaries last checked 18 November 2026.
Editorial methodology
These frameworks were developed and curated by Shamim Quresh, drawing on her professional practice in product development, formulation, manufacturing, branding and compliance.
They rely on published standards, regulations and established scientific principles, cited where they are used. That research and those publications are the work of their own authors and publishers.
AI tools assisted with drafting, structuring and checking the text, the interactive tools and the templates. Content is reviewed by Shamim before publication, and regulatory references were checked against official sources on the review date shown.
Worked examples, scenarios, results and data are illustrative. They do not describe experiments, tests or studies that Shamim has carried out, and no regulatory assessment of any product has been made.
Want to apply a framework to your own product?
I use these methods in consultancy work on product development, commercialisation, manufacturing and compliance. Tell me what you are building and where it is stuck.